CVR 37896950Private limited company (ApS)Ikke-finansielle holdingselskaber (642120)SilkeborgFounded 28 Jul 2016
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Juul III ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexResult
-7K
DKK, annual report 2025
Equity
247.3K
DKK, annual report 2025
Søren Juul Christensen100% of capital and votes, since 11 Oct 2021
Personal holding company
Dandex estimate: NACE 642120, controlled by a personSøren Juul Christensensince 11 Oct 2021
100% of capital and votessince 11 Oct 2021
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
50% to under 66.7% of capital and votesnotified 20 Sep 202128 Jul 2016 to 20 Sep 2021
100% of capital and votesnotified 20 Sep 202128 Jul 2016 to 11 Oct 2021
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report a calibrated decision model reading the auditor's text, not registered by the company. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
28 Jul 2016 to 13 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Not reported | Not reported | 0 | Not reported | Not reported |
| Operating profit | 0 | Not reported | -3 | 0 | 0 |
| Result for the year | -11 | -1 | +173 | +25 | -7 |
| Equity | 21 | 20 | 232 | 254 | 247 |
| Total assets | 21 | 20 | 281 | 270 | 256 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 0 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions.
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 13 Jan 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 11 Feb 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 7 Jan 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 8 Jan 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 14 Mar 2022
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For Juul III ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 13 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 13 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
8 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Ny adresse: c/o Søren Juul Christensen, Buskelundtoften 32, 8600 Silkeborg
Vedtægter ændret: 11.10.2021
Nyt navn: Juul III ApS
Ny adresse: c/o Søren Juul Christensen, Idasvej 35, 8600 Silkeborg
Ny kommune: Silkeborg
Direktion:
Fratrådte:
Direktør Rasmus Berger, den 11.10.2021.
Tiltrådte:
Søren Juul Christensen, den 11.10.2021.
Formål ændret: Selskabets formål er at besidde kapitalandele i andre erhvervsdrivende virksomheder samt at drive konsulentvirksomhed og dermed efter direktionens skøn beslægtet virksomhed.
Virksomheden er omregistreret fra Iværksætterselskab til Anpartsselskab
Vedtægter ændret: 20.09.2021
Nyt navn: RB Comparative ApS
Slettede binavne: Comparative IVS, Comparative Research IVS, Comparative R&D IVS
Kapitalforhøjelsen er besluttet den 20.09.2021.
kr. 30.000,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 40.000,00.
Direktion:
Fratrådte:
Morten Bo Søndergaard Svendsen, den 20.09.2021.
Selskabet tegnes af en direktør alene.
Formål ændret: Selskabets formål er at drive konsulentvirksomhed og dermed efter direktionens skøn beslægtet virksomhed.
Ny adresse: c/o Rasmus Berger, Lille Strandstræde 6A, 2. tv, 1254 København K
Ny adresse: c/o Rasmus Berger, Absalonsgade 3, 4. tv, 1658 København V
Binavne:
Comparative IVS UNDER TVANGSOPLØSNING
Comparative Research IVS UNDER TVANGSOPLØSNING
Comparative R&D IVS UNDER TVANGSOPLØSNING
Den under 31.08.2017 fremsendte anmodning til Sø- og Handelsrettens Skifteretsafdeling om opløsning af virksomheden, er tilbagetaget.
Direktion:
Tiltrådte:
Rasmus Berger, den 15.09.2017, Morten Bo Søndergaard Svendsen, den 15.09.2017.
Virksomheden tegnes af 2 direktører i forening.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 31.08.2017
Direktion:
Fratrådte:
Rasmus Berger, den 31.08.2017, Morten Bo Søndergaard Svendsen, den 31.08.2017.
Binavne: Comparative IVS, Comparative Research IVS, Comparative R&D IVS.
Stiftelsesdato: 28.07.2016.
Virkningsdato: 28.07.2016.
Seneste vedtægtsdato: 28.07.2016.
Kapital:
kr. 10.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 10.000,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
Rasmus Berger, den 28.07.2016, Morten Bo Søndergaard Svendsen, den 28.07.2016.
Direktion:
Rasmus Berger, den 28.07.2016, Morten Bo Søndergaard Svendsen, den 28.07.2016.
Virksomheden tegnes af direktionen..
Første regnskabsår:
28.07.2016 - 31.12.2016.
Regnskabsår:
01.01 - 31.12.
Formål:
Virksomhedens formål er at udvikle og sælge teknologisk udstyr til laboratoriebrug.
1 registered in CVR.
P-number 1021623128Buskelundtoften 32, 8600 Silkeborg
No other current company drawn.